The U.S. cryoablation probes market, valued at USD 51.71 million in 2024, is expected to reach USD 133.16 million by 2033, growing at an 11.16% CAGR. Growth is driven by rising cases of cardiovascular diseases and cancer, advanced technologies, and increased demand for minimally invasive procedures.
The U.S. cryoablation probes market, valued at USD 51.71 million in 2024, is expected to reach USD 133.16 million by 2033, growing at an 11.16% CAGR. Growth is driven by rising cases of cardiovascular diseases and cancer, advanced technologies, and increased demand for minimally invasive procedures.